Steven D. Miller - 17 May 2024 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 May 2024, 17:49:22 UTC
Prior SEC filing
26 Mar 2024
Next SEC filing
04 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brianna M. Cetrulo, attorney-in-fact

Key filing fact

Steven D. Miller filed Form 4 for Bausch Health Companies Inc. (BHC) on 20 May 2024.

Key facts

  • This page summarizes Steven D. Miller's Form 4 filing for Bausch Health Companies Inc. (BHC).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 20 May 2024, 17:49.

Change

  • Previous filing in this sequence was filed on 26 Mar 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BHC transaction

Common Shares, No Par Value

Award

Transaction value
$0
Shares
+35,360
Change %
+25%
Price
$0.000000
Shares after
174,877
Date
17 May 2024
Ownership
Direct
Footnotes
F1
BHC holding

Common Shares, No Par Value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,000
Date
17 May 2024
Ownership
By IRA
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .